Skip to main content
. 2017 Nov 28;9:122. doi: 10.1186/s13148-017-0422-7

Fig. 1.

Fig. 1

a, b Progression (PFS)- and treatment-free survival (TFS) according to cytogenetic risk groups. Kaplan–Meier survival curves from the date of diagnosis depicted for 127 chronic lymphocytic leukemia patients. Statistical differences between the curves were calculated using the log-rank test